Document is current

Article History

Received: 28 August 2025

Revised: 5 January 2026

Accepted: 9 January 2026

First Online: 1 April 2026

Declarations

:

: Healthy donors were recruited from AstraZeneca volunteers and all samples were taken following appropriate blood collection guidelines. All blood donor volunteers signed Informed Consent Form and donation was approved by AstraZeneca’s Human Biological Sample Governance Framwork and local Ethic committee Dnr:2019–03307 (033–10). This research utilized PBMC samples from follicular lymphoma (FL) patients who were enrolled in the GALEN clinical trial (NCT01582776). The research protocol was conducted under French legal guidelines and was approved by the local ethics committee.

: All participants provided informed consent for the use of their biological samples in research and publication of results in anonymized form.

: S.C., K.A., R.B., S.L., Y.C. and S.V. were fellows of the AstraZeneca R&D postdoc program. S.C., K.A., R.B., A.M., E.I., P.V., S.L., E.F.C., Y.C., S.V., M.F., L.W., H.G., M.M., M.H. and U.G. are or were employees of AstraZeneca and may own stock or stock options. U.G. is currently employed by Novartis.